Rapid Reversal of Warfarin Therapy in Patients with Intracranial / Intraspinal Bleeding Mount Auburn Hospital Blood Bank, Emergency Department, Critical.

Slides:



Advertisements
Similar presentations
Rapid Reversal of Warfarin Therapy in Patients with Intracranial / Intraspinal Bleeding Mount Auburn Hospital Blood Bank, Emergency Department, Critical.
Advertisements

Stroke Workshop Case Scenario.
What a Bloody Mess! A/Professor Kent Robinson Senior Staff Specialist, Liverpool & Campbelltown Hospitals.
Edward P. Sloan, MD, MPH Optimizing the Management of Emergency Department Intracerebral Hemorrhage Patients FERNE Satellite 2005 ACEP Scientific Assembly.
TPA… SMART or not SMART? That is the Question. Sarah Parker, MD.
Hyperacute Stroke Treatment: Inclusion and Exclusion Criteria
Brad Beckham T4. Definitions  Major blood loss Hemoglobin concentration below 6-10 g/dl  Massive transfusion in adults >9 erythrocyte units within 24h.
Blood Components Dosage And Their Administration
Faculty of Allied Medical Science
Andrew W. Asimos, MD Treating CNS Hemorrhage in the Anticoagulated Patient.
Prophylaxis of Venous Thromboembolism
Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric.
MTP Octaplex rFVIIa Calgary. Massive Transfusion Protocol.
Study by: Granger et al. NEJM, September 2011,Vol No. 11 Presented by: Amelia Crawford PA-S2 Apixaban versus Warfarin in Patients with Atrial Fibrillation.
Edward P. Sloan, MD, MPH, FACEP ED Hemorrhagic Stroke Patient Management: What Role for Operative Intervention & Factor VIIa?
Anticoagulation in Acute Ischemic Stroke. TPA: Tissue Plasminogen Activator 1995: NINDS study of TPA administration Design: randomized, double blind placebo-controlled.
Kcentra In-service Adam M. Spaulding, PharmD, BCPS
Dalia Elfawy., MD Lecturer of Anesthesia and ICU Ain Shams University 2014 RAPID REVERSAL OF ANTICOAGULATION IN TRAUMA PATIENTS.
NURS 1950 Pharmacology I 1.  Objective 1: identify general reasons anticoagulants are given 2.
Background Methods Results Conclusion Acknowledgements Printed by Multi-Institutional Audit of octaplex® & Comparison with National Recommendations S.
Prothrombin complex concentrate Octaplex
Care of the Anti-coagulated Trauma Patient Julie Mayglothling, MD, FACEP Emergencies in Medicine March 8 th, 2012.
Intracerebral Haemorrhage. Clinical Context ICH accounts for up to 15% of first-time strokes and is associated with a 30-day mortality rate between 35%
April 23, 2015 Mini-Lecture Nathan King M.D. Anticoagulation Reversal Part 2: UFH & LMWH.
Emergency management of complications of thrombolysis C. Roffe The recommendations in this presentation are for guidance only. Guidance based on ASA recommendations.
Emergency anticoagulant reversal B Vigué, DAR, CHU Bicêtre.
Management OF INTRACEREBRAL HEMORRHAGE
BLOOD TRANSFUSION NUR 317. TRANSFUSION Infusion of blood products for the purpose of restoring circulating volume.
Stroke and the ED Kurian Thomas, MD Department of Neurology.
FERNE/EMRA How do we treat ICH patients with an elevated INR Andy Jagoda, MD, FACEP Professor and Vice Chair Department of Emergency Medicine Mount Sinai.
Role of Factor Concentrates in Perioperative Coagulopathies Dr Neville Gibbs Department of Anaesthesia Sir Charles Gairdner Hospital.
Blood Product Administration Keith Rischer, RN. Erythrocytes  Function  Normal Life span  Norms Hgb –Women: g/dl –Men: n g/dl HCT –Women:
1 Ultra-rapid management of oral anticoagulant therapy- related surgical intracranial hemorrhage Intensive Care Medicine (2007) 33: Zohra Daw, MD,
Praxbind® - Idarucizumab
Case 60 F with PMH HTN, DM, CVA presented to UNC ED CC: seizure. Per the daughter the pt was walking and all of a sudden fell and her whole body started.
Anticoagulants and reversal
Anticoagulation Reversal May 11, Objectives Develop an approach for treating patients with iatrogenic coagulopathy Understand recent changes in.
Factor Eight Inhibitor Bypassing Activity (FEIBA) for the Rapid Reversal of Major Bleeding in Patients with Warfarin Induced Coagulopathy: A Pilot Study.
Fred V. Plapp MD PhD Pathology and Laboratory Medicine
Snakebite. History – 62 yo man Usually well, recently started antihypertensive Bite occurred 2 hours prior to arrival in ED Bitten saw large tiger snake.
{ Challenging Case Presentations From South Texas Methodist Hospital REGIONAL SYSTEMS OF CARE DEMONSTRATION PROJECT: MISSION: LIFELINE™ STEMI SYSTEMS ACCELERATOR.
Simon Howard Medical Management of Acute Stroke. Fast Recognition of Stroke With sudden onset neurological symptoms: 'FAST' should be used to screen for.
Blood Transfusions 1. Blood Administration Blood transfusion includes any of the following : whole blood packed RBC’s plasma platelets Purpose: 1.Increase.
April 23, 2015 Mini-Lecture Nathan King M.D. Anticoagulation Reversal Part 1: Warfarin.
Adult Stroke 2010 AHA Guidelines for CPR and ECC
Transfusion Christine Sullivan Transfusion Practitioner.
Copyright © 2016 A Real Headache: Anticoagulation and A Subdural Hematoma COPYRIGHT © 2016, ALL RIGHTS RESERVED From the Publishers of.
Approach To Bleeding Disorders In Neonates
ACLS CVA.
Prothrombin complex concentrate
د.محمد حارث الساعاتي.
AUB:Iatrogent Coagulopathy
You can never be too Thin…. An Update on NOACs
Warfarin Toxicity Treatment & Management
Evaluation of Four Factor Prothrombin Complex Concentrate
Anticoagulation Prepared by Cherie Gan.
Oral Anticoagulants and Reversal Agents
Click here for title Click here for subtitle
Performance Improvement: Emergency Management in Acute Cerebrovascular Patients Current US Guidelines Lisa A. Shultz, MD Medical Director, Lourdes Stroke.
Approach to Hemorrhagic and Ischemic Strokes
HYPERTENSIVE CRISES Mini-Lecture.
Oral Anticoagulant Reversal Agents
Anticoagulant Reversal
کزین برتر اندیشه بر نگذرد
A Real Headache: Anticoagulation and a Subdural Hematoma
Blood Components Dosage And Their Administration
RE-ALIGN Randomized, Phase II Study to Evaluate the Safety and Pharmacokinetics of Oral Dabigatran Etexilate in Patients after Heart Valve Replacement.
MOST Study Update and Protocol Refresher
Blood Transfusions Blood products (p.731) PRBC’s Frozen PRBC’s
Use Fixed low dose Prothrombin Complex Concentrate (Octaplex)
Presentation transcript:

Rapid Reversal of Warfarin Therapy in Patients with Intracranial / Intraspinal Bleeding Mount Auburn Hospital Blood Bank, Emergency Department, Critical Care, Neurosurgery, Hem-Onc, Quality and Safety

Clinical Questions What are the treatment options for anticoagulation reversal? How fast do they work? What are the risk factors? What is the Rapid Reversal of Warfarin Order-Set?

Background Life threatening bleeds in patients on wafarin - Timely reversal is IMPERATIVE! Current Treatment Options: FFP Concerns: Delayed treatment (thaw time), volume overload, inadequate correction Vitamin K IV Concerns: Length of onset time Prothrombin complex concentrate (PCC) Desmopressin (DDAVP) Increases levels of VWF and factor VIII Now Available

Evidence for Use of PCC

Evidence continued

Main Points: PCC normalizes INR faster than FFP PCC is recommended for patients with life-threatening warfarin related bleeding PCC, vitamin K IV, and FFP should all be available for this patient population

PCC: What is it? Also called: Kcentra Replaces: factor II, VII, IX and X (vit K dependent coag. Factors) Works by temporarily raising the levels of these clotting factors AHA / ASA class IIb recommendation

PCC: Risk factors Allergic reaction DIC Thrombosis Chills, headache, fever, nausea and vomiting, rash, anaphylactic reaction If this occurs, stop infusion and treat with antihistamines DIC Thrombosis

Rapid Reversal of Warfarin Order-set Restricted to the ED, Critical Care, and OR Indications: Intracranial or Intraspinal hemorrhage with elevated INR Exclusions: HIT in previous 3 months Relative contraindications: DIC, history of recent thrombosis, MI, Ischemic Stroke

Initial Work-up STAT head CT Notify blood back and core lab Alert: Neurosurgical Emergency, Name, and MR # STAT PT/INR, PTT, D-dimer, fibrinogen, CBC, in a bag labeled STAT to hematology STAT type and screen to blood bank STAT BMP and LFTs

Next Steps (per order-set) Administer Vitamin K 10 mg slow IV Administer PCC (Kcentra) INR < 5 500 IU of Kcentra IV INR > 5 1000 IU of Kcentra IV Rate: Do not exceed 5 ml per minute IV Push Administer Platelets if Plt < 100,000 DDAVP (Desmopressin) - consider if plt dysfunction present

Administration of PCC Available from the Blood Bank Needs to be reconstituted immediately prior to use Does not contain a preservative and must be used within 3 hours of reconstitution Do not refrigerate Concentrate should be drawn up with the contents in the package obtained from the blood bank Administer IV at a maximum rate of 5ml / min IVP

PCC IV Infusion How to prepare the medication Follow up Labs: You will receive a kit from the blood bank 2 minute administration video available at: www.kcentra.com Video listed under dosing and administration Note: The website indicates a weight based dosing with the INR. The dosing at MAH will only be based on INR. Follow up Labs: PT/INR 10 - 15 min after the infusion is complete

Case Study 71 yo M with sudden onset of a severe headache and blurred vision Vitals: BP 200/90, HR 92, RR 14, Temp 98 PMH: Afib, CAD, HTN, diabetes Medications: Warfarin 5mg daily Lopressor 25mg BID Lipitor 20mg daily Glucaphage 10mg BID

Case Study Continuted Head CT shows ICH Next Steps?

Summary Coagulopathy puts patients at high risk for ICH Vitamin K FFP Effective, but slow onset FFP Effective, but slow and risk of volume overload PCC - is effective and fast acting Orderset is available now under “evidence and ordersets” on the portal Orderset title: “Kcentra Rapid Reversal Warfarin”

References Chest 2008; 133 (6Suppl): 160S - 198S Stroke 2007; 38; 2001 - 2023 Yasaka M et al; Optimal dose of PCC for acute reversal of oral anticoagulation. Thromb Res. 2005; 115; 455 - 459 Nat’l Advisory Committee on Blood and Blood Products, September 2008